Form 4: Director George Brokaw Increases Stake in Chemours

Director George R. Brokaw acquired 7,182 shares of Chemours Co common stock as part of an equity grant.

Summary

• Director George R. Brokaw acquired 7,182 shares of Chemours Co (CC) common stock on May 6, 2026.
• The transaction was an acquisition at a price of $0, indicating an equity grant or compensation-related issuance.
• Following this transaction, the reporting person's total beneficial ownership increased to 21,642.7173 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing standard director compensation rather than a market-moving signal.

Positives

• Director alignment with shareholder interests is strengthened through increased equity ownership.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable as this is a routine insider transaction filing.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices intended to align board member incentives with long-term company performance.

Comparison to Industry Standards

• The acquisition of equity by directors is consistent with standard compensation practices for S&P 500 and chemical industry companies.

Stakeholder Impact

• Positive signal for shareholders regarding director commitment to the company.

Next Steps

• None.

Key Dates

Keywords

Chemours, CC, Insider Trading, Form 4, Director Ownership